Last update:

Infectious diseases news

Candida on urinary catheters can be more than contamination, patient samples suggest

Relying on a urinary catheter is a standard part of medical care for hundreds of thousands of patients each year. Unfortunately, the device carries the risk of catheter-associated urinary tract infections (CAUTIs), for which ...

New RNA vaccine strategy aims to build broader immunity against mutating viruses

New research by Malaghan's Connor Laboratory, published in PNAS, shows how directing the immune system toward conserved areas of the COVID virus and its many variants using RNA technology could be a significant step toward ...

Early trials for 'common cold' vaccine offer encouraging signs

A vaccine designed to protect against rhinoviruses, which cause the great majority of common colds and exacerbate chronic respiratory illnesses, has shown encouraging early results in a phase 1 clinical trial. Initial findings ...

Egyptian group developing Ebola vaccine

An Egyptian pharmaceutical firm is developing a potential vaccine against the deadly Ebola strain raging in the Democratic Republic of Congo (DRC), it announced Thursday.

WHO declares Uganda Ebola-free

Uganda was declared officially Ebola-free by the World Health Organization on Thursday after 42 days without a new case.

New approach cuts sepsis diagnosis from days to hours

Sepsis, a life-threatening condition that stems from the body trying to fight off an infection, plagues more than 1.5 million patients a year in the U.S. alone, with one in three deaths recorded in hospitals attributed in ...

How pregnancy itself drives deadly hepatitis E outcomes

Researchers have uncovered a biological mechanism that helps explain why hepatitis E virus infections can be especially severe—and often fatal—during pregnancy, finding that normal pregnancy-related hormonal changes inadvertently ...

Wastewater may offer an early warning of pertussis outbreaks

Pertussis, or whooping cough, continues to cause periodic outbreaks worldwide and can be especially dangerous for infants who have not completed vaccination. Yet conventional surveillance depends on people seeking medical ...

Hantavirus detected in France tourist now isolated in Spain

A case of hantavirus, which recently sparked international alarm, has been detected in a Franco-Argentine national who vacationed in France in July before being placed in isolation in Spain, the French Health Ministry said ...

US regulators approve Moderna flu vaccine

Vaccine manufacturer Moderna said Wednesday the U.S. Food and Drug Administration (FDA) had approved its new influenza vaccine, nearly six months after the regulator briefly rejected an application for review.

Night shift work linked to a higher risk of long COVID

The first evidence that night work and chronic insomnia may increase the risk of developing long COVID comes from a new study led by ISGlobal, a center supported by the "la Caixa" Foundation, in collaboration with the Germans ...

Severe COVID-19 reactivates dormant viruses, study finds

Chronically infecting viruses—such as Epstein-Barr virus, cytomegalovirus (CMV) and herpesviruses—are common and often innocuous and asymptomatic. However, emerging evidence suggests their reactivation may contribute to autoimmune ...

Meningococcal B vaccine linked to lower gonorrhea risk

The meningococcal B (MenB) vaccine could provide protection against more than one disease, with new research linking it to a significant reduction in the risk of gonorrhea in young Territorians. The study, led by Adelaide ...

Beyond COVID-19: Fundamental principles that shape pandemics

Every pandemic is different. Nevertheless, certain commonalities can be identified across all pandemics. Researchers at the Max Planck Institute for Dynamics and Self-Organization (MPI-DS), together with an interdisciplinary ...

Researchers discover immune 'off switch' used by cancer cells

Mayo Clinic researchers have identified a protein that cancer cells use to shut down the body's immune response, a discovery that could help scientists develop new treatments that make cancer immunotherapies more effective.